Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss

Fertility and Sterility

Volumn 87, Issue 4, 2007, Pages 976.e17-976.e18

  Oliver Miñarro, Desamparados ^a   Sanchez Ramón, Silvia ^a   Rodriguez Mahou, Margarita ^a   Álvarez, Silvia ^a   Fernández Cruz, Eduardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Antiphospholipid syndrome; fetal loss; ITP; M5 type AMA

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA 2 GLYCOPROTEIN I ANTIBODY; CARDIOLIPIN ANTIBODY; MITOCHONDRION ANTIBODY; MITOCHONDRION ANTIBODY TYPE 5; PARIETAL CELL ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; THYROID ANTIBODY; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FETUS WASTAGE; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

EID: 34047247173     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.07.1535     Document Type: Article

References (13)

1. La Rosa L., Covini G., Galperin C., Catelli L., Del Papa N., Reina G., et al. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies. Clin Exp Immunol 112 (1998) 144-151
2. Lamprecht P., Gause A., and Gross W.L. Cryoglobulinemic vasculitis. Arthritis Rheum 42 (1999) 2507-2516
3. Hanly J.G., and Smith S.A. Autoimmune antiphospholipid antibodies and cryoglobulinemia. Lupus 9 (2000) 264-270
4. Cervera R., and Asherson R.A. Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology 207 (2003) 5-11
5. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 353 (1999) 1348-1353
6. Laperche S., Abuaf N., Deschamps A., and Homberg J.C. Anti-mitochondrial antibodies type 5 are markers of antiphospholipid syndrome. Ann Biol Clin 52 (1994) 375-379
7. Meroni P.L., Harris E.N., Brucato A., Tincani A., Barcellini W., Vismara A., et al. Anti-mitochondrial type M5 and anticardiolipin antibodies in autoimmune disorders: studies on their association and cross-reactivity. Clin Exp Immunol 67 (1987) 484-491
8. Tincani A., Meroni P.L., Brucato A., Zanussi C., Allegri F., Mantelli P., et al. Antiphospholipid and anti mitochondrial type 5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 3 (1985) 321-326
9. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
10. Laperche S., Abuaf N., Meyer O., Carsique R., Deschamps A., Rajoely B., et al. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome. J Rheumatol 21 (1994) 1678-1683
11. Shoenfeld Y., and Blank M. Autoantibodies associated with reproductive failure. Lupus 13 (2004) 643-648
12. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74 (1995) 1185-1190
13. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311